Astrogen, inc. is a South Korea-based biopharmaceutical company specializing in the development of innovative small molecule therapies for neurological and rare diseases. Founded in 2017 by a pediatric neurologist, Astrogen leverages its clinical expertise and cutting-edge research to address unmet medical needs in conditions such as Autism Spectrum Disorder (ASD), Rett syndrome, Parkinson’s disease, and more.
Company Details
- Employees
- 5
- Founded
- 2017
- Address
- Daegu, Kr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.astrogen.co.kr/en
- HQ
- Daegu
Astrogen, Inc. Questions
Astrogen, Inc.'s website is http://www.astrogen.co.kr/en
Astrogen, Inc.'s LinkedIn profile is https://kr.linkedin.com/company/astrogen-inc
Astrogen, Inc. has
5 employees.
View email and phone details for 5
employees at Astrogen, Inc..
Astrogen, Inc.'s industry is
Biotechnology Research
Astrogen, Inc.'s top competitors are
Astrazeneca,
Voyager Therapeutics, Inc.,
Cureverse Inc.,
Medimabbio,
Aivis,
Acorn Applications Llc,
Vspharmtech 브이에스팜텍,
Neoimmunetech,
Astrozeina,
Astrogenesis.
Astrogen, Inc.'s categories are Biotechnology Research
Astrogen, Inc.'s founding year is 2017
